Why HEXO Stock Is Crashing Today

Shares of HEXO (NYSE:HEXO) were trading down by 17.3% as of 12:05 p.m. EDT on Friday, following the release of its…

Read more »

Aurora Cannabis: The 11,800% Gain No One Saw Coming

Over the next decade, marijuana is projected to be one of the fastest-growing industries. We already know that tens of billions of dollars in sales are currently conducted in the

Read more »

Is Aurora Cannabis About to Become a Micro-Cap?

About two years ago, Aurora Cannabis (NYSE:ACB) was considered one of the most promising marijuana companies. The pot grower was only second to Canopy Growth (NYSE:CGC) in terms of market cap at the time…

Read more »

2 Cannabis Stocks That Could Be Millionaire Makers

The marijuana industry is evolving at an incredibly fast pace in the U.S. and Canada. Many American states’ markets have handily beaten old sales highs in 2020. Illinois has seen

Read more »

7 Marijuana Stocks for an Election Day Boost

In this terribly contentious election cycle, there is an issue that seems to cut across otherwise deep-seated political and ideological beliefs: cannabis. Last month, Sen. Kamala Harris, the running mate

Read more »

Aurora Cannabis Inc. (ACB) Worth Considering For The Next Few Weeks

Taking a look at stock we notice that its last check on previous day was $4.85 and 5Y monthly beta was reading 0 with its price kept floating in the

Read more »

4 Best Cannabis Stocks Under $10

One of the best reasons to buy low-priced stocks is they often have more room to rise in value than higher-priced stocks, especially in the fast-growing cannabis industry. They can

Read more »

Should You Buy GW Pharmaceuticals Before They Report Earnings?

GW Pharmaceuticals (GWPH) has had a disappointing few months.  The company is expected to report its Q3 earnings results on November 3 and investors want to know if they can

Read more »

Aphria: Should Cannabis Investors ‘Buy the Dip’?

Aphria (APHA) reported its latest financial results before the market opened on October 15th and they came below analyst expectations. The market did not respond kindly, and…

Read more »

Is Tilray Stock a Buy?

Canadian cannabis cultivator Tilray (NASDAQ:TLRY) is in many ways a prototypical pot company: It’s unprofitable, its international value chain is overbuilt, and it competes in a handful of major cannabis product segments.

Read more »